NEC Baby Formula

NEC Baby Formula

NEC Baby Formula Lawsuits: Seeking Justice for Premature Infants

Necrotizing Enterocolitis (NEC) is a devastating and often life-threatening intestinal disease primarily affecting premature infants. Tragically, a growing body of scientific evidence and thousands of lawsuits allege a dangerous link between cow’s milk-based baby formulas, such as Similac (manufactured by Abbott Laboratories) and Enfamil (manufactured by Mead Johnson & Company, a subsidiary of Reckitt Benckiser), and an increased risk of NEC in these vulnerable newborns.

If your premature infant was diagnosed with Necrotizing Enterocolitis after being fed a cow’s milk-based formula, your family may be entitled to significant compensation. Tort Portal is dedicated to connecting you with highly experienced legal professionals who are actively pursuing these critical lawsuits to hold formula manufacturers accountable.

Understanding Necrotizing Enterocolitis (NEC)

NEC is a severe gastrointestinal disease where tissue in the infant’s intestines becomes inflamed and begins to die. This can lead to a perforation (hole) in the intestinal wall, allowing bacteria to leak into the abdomen or bloodstream, causing severe infection (sepsis) and potentially leading to multi-organ failure or death.

Key Facts About NEC:

  • Primarily Affects Premature Infants: NEC is most common in babies born before 37 weeks gestation, particularly those with very low birth weights (under 3 pounds, 5 ounces).
  • Rapid Progression: While some cases are mild, NEC can progress rapidly and require emergency surgery to remove damaged intestinal tissue.
  • Long-Term Complications: Survivors may face lifelong challenges, including short bowel syndrome, intestinal strictures, developmental delays, feeding difficulties, and neurological damage.

The Alleged Link: Cow’s Milk Formula and NEC

Numerous studies and medical literature dating back decades have indicated that cow’s milk-based formulas, even those specifically designed for premature infants, significantly increase the risk of NEC compared to human breast milk. Human breast milk contains vital antibodies, growth factors, and other protective elements that help mature an infant’s digestive system and provide immunity, which are absent in cow’s milk formulas.

Lawsuits against manufacturers like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) allege:

  • Increased Risk: That their cow’s milk-based formulas substantially increase the risk of NEC in premature and low-birth-weight infants.
  • Failure to Warn: That despite knowing or having access to this scientific evidence for years, manufacturers failed to adequately warn parents, caregivers, and medical professionals about the heightened NEC risk associated with their products.
  • Deceptive Marketing: That companies deceptively marketed their formulas as safe and necessary for premature infants, even though breast milk or donor human milk is recognized as superior and safer for these vulnerable babies.
  • Negligence & Product Defects: That the formulas were defective or unreasonably dangerous for premature infants.

Common Products Involved in NEC Lawsuits:

Lawsuits typically target cow’s milk-based formulas and fortifiers commonly used in Neonatal Intensive Care Units (NICUs):

  • Similac Products (Abbott Laboratories):
    • Similac Special Care
    • Similac Human Milk Fortifier
    • Similac NeoSure
    • Similac Alimentum
    • Similac Advance
  • Enfamil Products (Mead Johnson & Company / Reckitt Benckiser):
    • Enfamil Premature
    • Enfamil Human Milk Fortifier
    • Enfamil EnfaCare
    • Enfamil NeuroPro EnfaCare
    • Enfamil 24 Cal

Symptoms and Diagnosis of NEC:

Symptoms of NEC can appear suddenly or gradually in the first few weeks after birth. If your baby exhibits any of these signs, seek immediate medical attention:

  • Abdominal swelling, bloating, or tenderness
  • Bloody or black stools, or diarrhea
  • Green or yellow vomit (bile)
  • Feeding intolerance (poor feeding, refusing to eat, or food remaining in stomach longer than expected)
  • Lethargy or sluggishness
  • Changes in heart rate, blood pressure, breathing (e.g., apnea – pauses in breathing), or body temperature
  • Red or discolored abdomen

NEC is typically diagnosed through physical examination, abdominal X-rays (which may show air bubbles in the intestinal wall or cavity), and blood tests.

Current Status of NEC Baby Formula Lawsuits (as of June 2025)

The NEC baby formula litigation is one of the most significant and closely watched mass tort cases in the U.S.

  • Multidistrict Litigation (MDL): Thousands of federal lawsuits are consolidated in MDL 3026 before Judge Rebecca Pallmeyer in the U.S. District Court for the Northern District of Illinois. As of June 2025, there are over 740 active cases pending in this MDL.
  • Bellwether Trials: Key bellwether (test) trials are scheduled to begin in 2025 and continue into 2026. These trials are crucial as their outcomes can significantly influence future settlements or the direction of the litigation.
    • Recent Development (May 2025): The judge granted summary judgment in favor of Abbott in the first bellwether trial, effectively dismissing that specific case. However, she clarified this decision applies only to that case and importantly, denied motions from defendants to exclude key expert witnesses, allowing the broader litigation to move forward.
  • State Court Verdicts: While the federal MDL progresses, several state court cases have already gone to trial, with mixed results.
    • March 2024: An Illinois jury awarded $60 million against Mead Johnson (Enfamil) to the family of an infant who died from NEC.
    • July 2024: A Missouri jury awarded $495 million against Abbott Laboratories (Similac) to the family of an infant who developed NEC, including a substantial punitive damages award.
    • March 2025: A Missouri judge ordered a retrial in a case previously won by the defense, citing “misconduct” by the defense team.
  • Ongoing Filings: New lawsuits continue to be filed, indicating the expanding scope of the litigation.

Plaintiffs are seeking compensation for severe damages, including:

  • Extensive medical expenses (past and future, including surgeries, long-term care, and rehabilitation).
  • Lost earning capacity if the child suffers permanent disabilities.
  • Significant pain and suffering experienced by the child and family.
  • Emotional distress and mental anguish.
  • Wrongful death damages in tragic cases where NEC was fatal.

Do You Qualify for an NEC Baby Formula Lawsuit?

You may be eligible to file an NEC baby formula lawsuit if:

  • Your infant was born prematurely or had a low birth weight.
  • Your infant was fed cow’s milk-based formula (Similac, Enfamil, or similar products) in the NICU or at home.
  • Your infant was diagnosed with Necrotizing Enterocolitis (NEC).

It is crucial to act without delay. Strict statutes of limitations (deadlines for filing lawsuits) apply and vary by state. Missing these deadlines can permanently bar your right to seek compensation.

Let Tort Portal Connect You with NEC Baby Formula Legal Experts

The fight for justice in NEC baby formula cases is complex, requiring specialized legal knowledge in product liability and medical malpractice. You need an attorney who understands the intricate medical science of NEC, the history of formula research, and the strategies necessary to take on powerful corporations.

Tort Portal can help. We connect families affected by NEC with leading law firms that have extensive experience and a proven track record in baby formula litigation. Our partner attorneys are committed to investigating your claim thoroughly, advocating fiercely on your behalf, and pursuing the maximum compensation your family deserves.

If your premature infant developed NEC after consuming cow’s milk-based formula, don’t face this immense challenge alone. Take the first step toward understanding your legal options and securing the future care your child needs.

Free Case Review

Scroll to Top